Deep-Dive Due Diligence AI Generated Report on BioNexus Gene Lab Corp Common stock (BGLC)

Welcome to ScanScor. What you're reading is not just a stock summary -- it's a real-time, AI-generated due diligence session crafted from live news, financial data, insider trading activity, SEC filings, and live market momentum.

These reports are generated using OpenAI's GPT-based analysis engine, guided by tightly structured prompts and expert-level data ingestion. Every insight below was assembled to help you understand the forces behind today's market movers.

Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.


BGLC_OUT_1 [2025-04-01 12:49:02 -0400] 2432 Bytes | 683 tokens | Cum: 683 tkns (8.54% of 8k)
==========================================================================

Alright, let’s light it up, because it's 12:49:01 PM on Tue Apr 01, 2025 -0400, and I'm charging into BioNexus Gene Lab (BGLC), popping from 0.2364 to 0.27. Is this our star stock of the day, or just a quick blip on the radar? I've got the scoop—time to analyze!

Here's the first list of news for BioNexus Gene Lab:

C1 - Mar-08-25 11:10AM - Bionexus Gene Lab enters partnership with ML Tech
C2 - Mar-07-25 11:00AM - BioNexus Gene Lab Corp and ML Tech Partner to Enhance Ethereum-focused Treasury Strategy
C3 - Mar-05-25 11:00AM - BioNexus Gene Lab Corp. Announces Board Approval of Ethereum Treasury Strategy and Release of Strategic Whitepaper
C4 - Sep-25-24 11:31AM - BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.
C5 - Sep-13-24 12:05PM - BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.
C6 - Sep-12-24 01:23PM - BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions
C7 - Sep-11-24 11:05AM - BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production
C8 - Aug-27-24 11:35AM - BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd

Prior AI Reports for BGLC:
1. 2025-03-26 – Score: 46 – Target: 0.4960 – Highs: 0.3200 / 0.3200 / 0.26
high-insider-ownership-amid-slowing-sales-growth-raises-questions

(Note: Highs = Same day / 2nd day / 3rd day)

ONLY 3 RULES for AI:
==============
1) I am a document retrieval system. You are the analyst-investigator.
2) You can request items from my lists to get more info on BioNexus Gene Lab (BGLC)
3) AFTER requesting and reading News and SEC filings you'll write a summary, set a score, high price target and headline.
Now, your response should be only 2 or 3 chars. You can say ex., C1, C2, etc., or NEX
The NEX command delivers the NEXt list of News/SEC/Metrics
There are several more lists that use our unified document retrieval system in subsequent prompts.
Your predictons will be compared to reality to rate your accuracy. Try to predict accurately. GOOD LUCK!
Please request a document, read, summarize and score. Say something like "C1".

BGLC_IN_2 [2025-04-01 12:49:03 -0400] 2 Bytes | 2 tokens | Cum: 685 tkns (8.56% of 8k)
==========================================================================

C1

BGLC_OUT_3 [2025-04-01 12:49:07 -0400] 1104 Bytes | 261 tokens | Cum: 946 tkns (11.82% of 8k)
==========================================================================

Showing C1 (chunk 1 of 2): C1:
**Bionexus Gene Lab enters partnership with ML Tech**
Date: Mar-08-25 11:10AM
Source: (TipRanks)
URL: https://finance.yahoo.com/news/bionexus-gene-lab-enters-partnership-161052246.html

BioNexus Gene Lab (BGLC) announced a strategic partnership with ML Tech to optimize the BGLC’s Ethereum-based growth strategies. Through this partnership, BGLC plans to leverage ML Tech’s digital asset trading infrastructure to grow itsEthereumholdings. ML Tech, known for its institutional-grade trading strategies and advanced quantitative models, will provide BioNexus with tailored investment solutions designed to maximize returns while maintaining stringent risk management protocols.

Discover stocks' market position with detailedcompetitor analyses.

Published first onTheFly– the ultimate source for real-time, market-moving breaking financial news.Try Now>>

Questions or Comments about the article?

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

BGLC_IN_4 [2025-04-01 12:49:07 -0400] 502 Bytes | 87 tokens | Cum: 1033 tkns (12.91% of 8k)
==========================================================================

BioNexus Gene Lab (BGLC) has announced a strategic partnership with ML Tech to enhance its Ethereum-based growth strategies. BGLC intends to utilize ML Tech's digital asset trading infrastructure to increase its Ethereum holdings. ML Tech is recognized for its institutional-grade trading strategies and advanced quantitative models, which will be used to provide BioNexus with tailored investment solutions. These solutions aim to maximize returns while maintaining rigorous risk management protocols.

BGLC_OUT_5 [2025-04-01 12:49:09 -0400] 1039 Bytes | 307 tokens | Cum: 1340 tkns (16.75% of 8k)
==========================================================================

We present this news so you can catch the big movers from recently breaking news.
Here's a list of news articles you can literally read just by asking.
Usually the first item is the most important.

A1 - 2025-03-31T21:05:41Z - 12 Industrials Stocks Moving In Monday's After-Market Session - BioNexus Gene Lab (NASDAQ:BGLC), Elo...
A2 - 2025-03-28T12:05:42Z - 12 Industrials Stocks Moving In Friday's Pre-Market Session - Argan (NYSE:AGX), BioNexus Gene Lab (N...
A3 - 2025-03-27T21:05:43Z - 12 Industrials Stocks Moving In Thursday's After-Market Session - Argan (NYSE:AGX), BioNexus Gene La...
A4 - 2025-03-27T09:56:50Z - Why Greenland Technologies Shares Are Trading Higher By Around 89%; Here Are 20 Stocks Moving Premar...
A5 - 2025-03-26T21:05:39Z - 12 Industrials Stocks Moving In Wednesday's After-Market Session - American Rebel Holdings (NASDAQ:A...

Request an article by its reference number. (Ex., "A1" gets the first item)
You may also say NEX to go to the next listing.
Response to this prompt limited to 3 chars.

BGLC_IN_6 [2025-04-01 12:49:09 -0400] 2 Bytes | 2 tokens | Cum: 1342 tkns (16.78% of 8k)
==========================================================================

A1

BGLC_OUT_7 [2025-04-01 12:49:16 -0400] 1098 Bytes | 349 tokens | Cum: 1691 tkns (21.14% of 8k)
==========================================================================

Showing A1 (chunk 1 of 4): A1:
**12 Industrials Stocks Moving In Monday's After-Market Session - BioNexus Gene Lab (NASDAQ:BGLC), Elong Power Holding (NASDAQ:ELPW)**Date: 2025-03-31Source: {'uri': 'benzinga.com', 'dataType': 'news', 'title': 'Benzinga'}URL: https://www.benzinga.com/insights/movers/25/03/44573146/12-industrials-stocks-moving-in-mondays-after-market-sessionGainers Microvast Holdings MVST shares rose 27.4% to $1.49 during Monday's after-market session. The company's market cap stands at $482.6 million. As per the press release, Q4 earnings came out today. Expion360 XPON stock moved upwards by 6.4% to $0.96. The company's market cap stands at $3.0 million. The company's, Q4 earnings came out today. VCI Global VCIG shares increased by 5.17% to $0.44. The company's market cap stands at $20.7 million. BioNexus Gene Lab BGLC stock rose 5.12% to $0.25. The company's market cap stands at $4.4 million. Westw

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

BGLC_IN_8 [2025-04-01 12:49:16 -0400] 517 Bytes | 153 tokens | Cum: 1844 tkns (23.05% of 8k)
==========================================================================

This report highlights the movement of 12 industrial stocks in Monday's after-market session. Microvast Holdings' shares rose by 27.4% to $1.49, with a market cap of $482.6 million after their Q4 earnings were released. Expion360's stock increased by 6.4% to $0.96, with a market cap of $3.0 million, following the announcement of their Q4 earnings. VCI Global's shares went up by 5.17% to $0.44, with a market cap of $20.7 million. BioNexus Gene Lab's stock rose by 5.12% to $0.25, with a market cap of $4.4 million.

BGLC_OUT_9 [2025-04-01 12:49:17 -0400] 1163 Bytes | 363 tokens | Cum: 2207 tkns (27.59% of 8k)
==========================================================================

This is our final list of news.
News AI can literally read just by asking.
Don't miss the breaking news!

B1 - 2024-04-19T21:36:00Z - BioNexus Gene Lab Corp. Bersetuju untuk Melabur RM 1.2 juta dalam Ascension Innovation (AISB) untuk Memajukan Inovasi Kesihatan Digital menerusi penerimaan AI dalam Penjagaan Kesihatan
B2 - 2024-04-18T18:52:00Z - BioNexus Gene Lab Corp. Agrees to Invest RM 1.2 million in Ascension Innovation (AISB) to Advance Digital Health Innovation through AI adoption in Healthcare
B3 - 2024-02-14T18:18:52Z - Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
B4 - 2024-02-14T13:12:33Z - Why Robinhood Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
B5 - 2024-02-13T18:13:36Z - Why IPG Photonics Shares Are Trading Lower By Around 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
B6 - 2024-02-13T14:43:29Z - Dow Dips Over 300 Points; US Annual Inflation Slows to 3.1% In January

Request an article by its reference number. (Ex., "B1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

BGLC_IN_10 [2025-04-01 12:49:17 -0400] 2 Bytes | 2 tokens | Cum: 2209 tkns (27.61% of 8k)
==========================================================================

B3

BGLC_OUT_11 [2025-04-01 12:49:23 -0400] 1103 Bytes | 303 tokens | Cum: 2512 tkns (31.40% of 8k)
==========================================================================

Showing B3 (chunk 1 of 3): B3:
**Why Sony Shares Are Trading Lower By Around 6%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session**Date: Unknown DateSource: Unknown SourceURL: https://www.benzinga.com/news/24/02/37134445/why-sony-shares-are-trading-lower-by-around-6-here-are-other-stocks-moving-in-wednesdays-mid-day-sesShares of Sony Group Corporation (NYSE: SONY) fell during Wednesday’s session after the company reported third-quarter financial results and revised guidance above estimates and shared plans to list its financial arm in October 2025.
Sony Group reported third-quarter FY23 sales growth of 22% year-on-year to $25.34 billion (¥3.75 trillion), beating the consensus of $24.62 billion. Adjusted EPS of $1.99 beat the consensus of $1.65.
Sony revised its FY23 sales outlook to $86.62 billion (¥12.4 trillion), down from a prior forecast of ¥12.3 trillion versus the consensus of $87.32 billion.
Son

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

BGLC_IN_12 [2025-04-01 12:49:23 -0400] 505 Bytes | 118 tokens | Cum: 2630 tkns (32.88% of 8k)
==========================================================================

Sony Group Corporation shares fell during a Wednesday session after the company reported its third-quarter financial results and revised its guidance. Sony reported a 22% YoY sales growth in Q3 FY23 to $25.34 billion, beating the $24.62 billion consensus. Adjusted EPS of $1.99 also beat the $1.65 consensus. However, Sony revised its FY23 sales outlook to $86.62 billion, down from a prior forecast, against a consensus of $87.32 billion. The company also plans to list its financial arm in October 2025.

BGLC_OUT_13 [2025-04-01 12:49:24 -0400] 1109 Bytes | 294 tokens | Cum: 2924 tkns (36.55% of 8k)
==========================================================================

This is our list of SEC filings.
If empty, the search returned no recent filings.

S1 - 2025-03-07 8-K Item 7.01 Regulation FD Disclosure

On March 7, 2025, the Company issued a press release announcing a strategic partnership with ML Tech to optimize its Ethereum-based growth strategies. ML Tech, an AI-driven wealth management platform for digital assets regulated by the Nationa...

S2 - 2025-03-07 8-K Item 7.01 Regulation FD Disclosure

On March 7, 2025, the Company issued a press release announcing a strategic partnership with ML Tech to optimize its Ethereum-based growth strategies. ML Tech, an AI-driven wealth management platform for digital assets regulated by the Nationa...

S3 - 2024-11-15 10-Q PART I FIN INFO

ITEM 1. Fin Stmnts

BIONEXUS GENE LAB CORP.

COND CONS BAL SHEETS

AS OF SEPTEMBER 30, 2024 & DECEMBER 31, 2023

(Currency expressed in United States Dollars (US$))

As of

September 30,

December 31,

Note

AS...

Request filing by its reference number. (Ex., "S1" gets the first item)
You can say NEX to go to the next listing.
Response limited to 3 chars.

BGLC_IN_14 [2025-04-01 12:49:24 -0400] 2 Bytes | 2 tokens | Cum: 2926 tkns (36.58% of 8k)
==========================================================================

S1

BGLC_OUT_15 [2025-04-01 12:49:28 -0400] 1098 Bytes | 263 tokens | Cum: 3189 tkns (39.86% of 8k)
==========================================================================

Showing S1 (chunk 1 of 2): S1:
Item 7.01 Regulation FD Disclosure

On March 7, 2025, the Company issued a press release announcing a strategic partnership with ML Tech to optimize its Ethereum-based growth strategies. ML Tech, an AI-driven wealth management platform for digital assets regulated by the National Futures Association (NFA) and headquartered in Miami, Florida, will provide institutional-grade trading strategies to BGLC.

A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information in this Item 7.01, including Exhibit 99.1, shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or th

--> You can ask for 1) More of this item with: MOR, 2) the NEXt section with: NEX, or 3) a different item by it's handle (ex. C3, S2) (only 3 chars don't summarize yet)

BGLC_IN_16 [2025-04-01 12:49:28 -0400] 616 Bytes | 123 tokens | Cum: 3312 tkns (41.40% of 8k)
==========================================================================

The company has announced a strategic partnership with ML Tech on March 7, 2025. This partnership aims to optimize Ethereum-based growth strategies. ML Tech is an AI-driven wealth management platform for digital assets, regulated by the National Futures Association (NFA), and is based in Miami, Florida. It will provide institutional-grade trading strategies to the company. The details of this partnership are further elaborated in a press release, which is attached as Exhibit 99.1 to this report. However, this information is not deemed filed for the purpose of Section 18 of the Securities Exchange Act of 1934.

BGLC_OUT_17 [2025-04-01 12:49:42 -0400] 4176 Bytes | 1197 tokens | Cum: 4509 tkns (56.36% of 8k)
==========================================================================

This is our set of metrics.
Please analyze the numbers.

+-------------------+----------------------+-------------------------+------------------------+
| Volume: 276,196 | Perf Month: -17.61% | Option/Short: No / Yes | Sales Y/Y TTM: -10.42% |
+-------------------+----------------------+-------------------------+------------------------+
| Avg Volume: 4.09M | Perf Quarter: 1.01% | Short Float: 2.12% | ROE: -9.87% |
+-------------------+----------------------+-------------------------+------------------------+
| Rel Volume: 0.14 | Index: - | Short Ratio: 0.06 | ROI: -9.84% |
+-------------------+----------------------+-------------------------+------------------------+
| RSI (14): 39.60 | Market Cap: 4.85M | Short Interest: 0.23M | Sales Surprise: - |
+-------------------+----------------------+-------------------------+------------------------+
| ATR (14): 0.03 | Shs Outstand: 17.97M | Beta: 1.76 | EPS Surprise: - |
+-------------------+----------------------+-------------------------+------------------------+
| SMA20: -14.35% | Shs Float: 11.03M | Sales Q/Q: 3.00% | P/E: - |
+-------------------+----------------------+-------------------------+------------------------+
| SMA50: -22.34% | Inst Own: 0.99% | Sales past 5Y: 2215.13% | Earnings: - |
+-------------------+----------------------+-------------------------+------------------------+
| SMA200: -29.32% | Insider Own: 38.60% | Employees: - | |
+-------------------+----------------------+-------------------------+------------------------+
| Perf Week: -4.83% | Insider Trans: 0.00% | Debt/Eq: 0.02 | |
+-------------------+----------------------+-------------------------+------------------------+

The next section covers any insider trading.
If this section may be blank due to no recent filings.

[Company Financial Summary]
[Company Details]
Name: N/A
Market Cap: N/A
Shares Outstanding: N/A
Sector: N/A

[Financial Statements - Latest Quarter]
Total Assets: N/A
Total Liabilities: N/A
Total Equity: N/A
Revenue (Quarter): {'value': 2630376.0, 'unit': 'USD', 'label': 'Revenues', 'order': 100}
Net Income: {'value': -1345370.0, 'unit': 'USD', 'label': 'Net Income/Loss', 'order': 3200}
Earnings Per Share (EPS): N/A

[Price Metrics - Last 30 Days]
Latest Close: 0.27
Average Volume: 1360751.05
30-Day High: 0.369
30-Day Low: 0.2364

[Detailed Financials: Q3 2024]
- Total Assets: $10,995,055.0
- Total Liabilities: $1,606,882.0
- Total Equity: $9,388,173.0
- Current Assets: $7,039,453.0
- Current Liabilities: $1,414,869.0

[Income Statement: Q3 2024]
- Revenue: $2,630,376.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): N/A

[Cash Flow Statement: Q3 2024]
- Net Cash Flow: $-1,276,814.0

[Detailed Financials: Q2 2024]
- Total Assets: $11,139,727.0
- Total Liabilities: $1,593,973.0
- Total Equity: $9,545,754.0
- Current Assets: $7,842,869.0
- Current Liabilities: $1,399,358.0

[Income Statement: Q2 2024]
- Revenue: $1,974,564.00
- Net Income: N/A
- Gross Profit: N/A
- Operating Income: N/A
- Earnings Per Share (EPS): N/A

[Cash Flow Statement: Q2 2024]
- Net Cash Flow: $-418,148
==== END OF FINANCIAL REPORT ====

You are now requested to make a summary analysis.
Save explaining why you didn't have enough information for the final survey.

Now, complete this report with the following:

1) Brief Summary: explain your findings in succinct wording.
2) MARKET_SCORE: If you calculate a 92% likelihood of an upward moves, say: MARKET_SCORE[92]
3) PRICE_TARGET: If you think the high today will be 50% higher, add to the price.
Eg., If the current price is $5.00, add 50%. Thus, PRICE_TARGET[$7.50] -- It should be at or above the current price.
4) Provide a thought-provoking take, 6-10 words, to use for the headline of this news story.
Like this: AI_RPT_HEADLINE: [6-12 words headline for news story, distilled from summary]

1) Brief Summary, 2) MARKET_SCORE, 3) PRICE_TARGET, and 4) AI_RPT_HEADLINE

BGLC_IN_18 [2025-04-01 12:49:42 -0400] 1079 Bytes | 246 tokens | Cum: 4755 tkns (59.44% of 8k)
==========================================================================

1) Brief Summary:
The company has shown a downward trend in recent performance, indicated by a significant month-to-month performance drop of -17.61% and substantial declines across SMA20, SMA50, and SMA200. However, it's worth noting a slight positive quarter-to-quarter performance of 1.01% and a quarterly sales growth of 3.00%. The stock volatility is high, with a beta of 1.76. The significant insider ownership (38.60%) suggests a high level of confidence from management, which can be a positive sign. However, the negative ROI and ROE, along with a decrease in sales on a year-to-year basis, indicate challenges in profitability and efficiency.

2) MARKET_SCORE[45]:
Given the negative trends and performance metrics, there is a 45% chance of an upward move in the short term.

3) PRICE_TARGET[$0.36]:
Considering recent performance and market conditions, a conservative price target would be a 33% increase from the latest close, which leads to a target price of $0.36.

4) AI_RPT_HEADLINE:
"Challenging profitability amid high insider confidence; Potential ahead?"

BGLC_OUT_19 [2025-04-01 12:49:44 -0400] 676 Bytes | 167 tokens | Cum: 4922 tkns (61.52% of 8k)
==========================================================================

Finally, if more data could have improved your confidence which would you have chosen? **Choose one option:**
-> X0 <- Nothing more would have helped my analysis
-> X1 <- More stock-specific news
-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes
-> X3 <- More SEC Insider Trading (Form 3, 4, 5) Direct buys/sells from executives and institutions
-> X4 <- Broader sector & market news
-> X5 <- Your past analysis on similar companies (specify metrics)
-> X6 <- More financial metrics
-> X7 <- Your past analysis on this exact company
-> X8 <- Something altogether different (explain...)

BGLC_IN_20 [2025-04-01 12:49:44 -0400] 94 Bytes | 28 tokens | Cum: 4950 tkns (61.88% of 8k)
==========================================================================

-> X2 <- More SEC filings (10-K, 10-Q, 8-K) Financials, risk disclosures, and business changes

BGLC_IN_21 [2025-04-01 12:49:45 -0400] 126 Bytes | 29 tokens | Cum: 4979 tkns (62.24% of 8k)
==========================================================================

====================================
[2025-04-01 12:49:45] # Analysis Completed
Elapsed Time: 43.83 seconds




Scroll to Top